I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.
Isoguvacine·HCl is an agonist of γ-amino butyric acid receptor. Isoguvacine interactions have many similar biochemical features of GABA synaptic function. Isoguvacine·HCl is a specific GABAA receptor agonist. This compound suppresses low magnesium induced seizure like events in organotypic hippocampal brain slices.
Willian Seiji Korim.; Simon McMullan.; Sergio L. Cravo.; Paul M. Pilowsky. Asymmetrical changes in lumbar sympathetic nerve activity following stimulation of the sciatic nerve in rat. Brain Research. 2011, 1391, 60-70.
Takako Shimidzu.; Yoshinori Itoh.; Michiko Oka.; Tsuyoshi Ishima.; Yojiro Ukai.; Yoshiaki Yoshikuni.; Kiyoshi Kimura. Effect of a novel cognition enhancer NS-105 on learned helplessness in rats: Possible involvement of GABAB receptor up-regulation after repeated treatment. European Journal of Pharmacology. 1997, 338,(3), 225-232.
Hazard Statements: H315-H319-H335
Causes skin irritation. Causes serious eye irritation. May cause respiratory irritation.
Precautionary Statements: P261-P280a-P305+P351+P338-P304+P340-P405-P501a
Avoid breathing dust/fume/gas/mist/vapours/spray. Wear protective gloves and eye/face protection. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. IF INHALED: Remove to fresh air and keep at rest in a position comfortable for breathing. Store locked up. Dispose of contents/container in accordance with local/regional/national/international regulations.